A scientific event to introduce the products of Trita Third Millennium Pharmaceutical Company, under the brand names COMFOTRIT® and ORSENSE® on September 5, 2022, coinciding with Hakim Zakaria Razi’s birthday and Pharmacy Day, with the presence of a group of physicians, pharmacists, experts and officials in the field of medicine and pharmacy was held at Evin Parsian Hotel.
During this event, Dr. Seyed Hamid Mostafavi, the CEO of Trita Third Millennium Pharmaceutical Company, said that COMFOTRIT® suspension is a unique anti-reflux medicine for the treatment of Gastroesophageal Reflux Disease (GERD), which was first formulated and introduced in Iran by this company.
He promised that this medicine will soon enter the pharmaceutical market of the country and will be available to patients at a more reasonable price than it’s foreign sample (Gaviscon®).
By creating a protective layer as a protective barrier on the contents of the stomach, COMFOTRIT®, prevents the return of stomach acid to the esophagus and relieves the burning sensation in the chest.
During this event, the other product produced by this company, ORSENSE® solution, was also introduced. This product, which is an oral solution, has been modified in taste and contains zinc as an effective ingredient in treating diarrhea and helping the faster recovery of water and electrolytes that body has lost.
Also with it’s ease of use and increased patient compliance, this product will have an added value compared to other products available in the domestic market.